SCHEMBL23367388

SCHEMBL23367388

Cc1cccc(-n2ncc(C=O)n2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
PAX8 Q06710 1/20 0.41
HSP90AA1 P07900 1/20 0.40
MGLL Q99685 1/20 0.40
ALDH1A1 P00352 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
ADORA2A P29274 1/20 0.39
KMT2A Q03164 2/20 0.38
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
RPA1 P27694 1/20 0.36
NPBWR1 P48145 1/20 0.36
MCHR1 Q99705 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5487008 0.83 PKM (0.43) P2RX7NPC1RAB9AMGLLALDH1A1
SCHEMBL11696173 0.80 P2RX7 (0.42) P2RX7NPC1RAB9AMGLLALDH1A1
SCHEMBL9814514 0.80 P2RX7 (0.62) P2RX7NPC1RAB9AALDH1A1ADORA2A
SCHEMBL23385108 0.74 RPA1 (0.44) NPC1RAB9APAX8HSP90AA1MGLL
SCHEMBL15578745 0.74 RPA1 (0.53) NPC1RAB9APAX8HSP90AA1MGLL
SCHEMBL26251816 0.73 MAPK14 (0.42) NPC1RAB9APAX8HSP90AA1MGLL
SCHEMBL4251316 0.73 MEN1 (0.54) P2RX7NPC1RAB9APAX8HSP90AA1
SCHEMBL2896761 0.72 GRM5 (0.44) NPC1RAB9APAX8HSP90AA1MGLL
SCHEMBL28434913 0.72 RAB9A (0.48) NPC1RAB9AALDH1A1L3MBTL1ADORA2A
SCHEMBL23367361 0.71 P2RX7 (0.37) P2RX7MGLLALDH1A1L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021094434-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2021-05-20 WO disclosed
EP-3822265-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer AG (DE) 2021-05-19 EP disclosed